Search - tctmd.com

Displaying 261 - 280 of 454

Sort: Relevancy | Date

News Daily News

H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds?

Shelley Wood

November 05, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Caitlin E. Cox

October 29, 2020

News Daily News

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Todd Neale

October 29, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Daily News

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Michael O'Riordan

October 23, 2020

News Daily News

As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage

Shelley Wood

October 22, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Presenter: Byeong-Keuk Kim

October 14, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Advertisement

H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds?

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

TCTMD’s Top 10 Most Popular Stories for October 2020

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Treating Accessory Arteries May Be Important in Renal Denervation

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content